期刊文献+

胺碘酮对老年急性心肌梗死合并心房颤动患者短期预后影响研究 被引量:11

Effect of amiodarone on short-term prognosis in elderly patients with AMI complicated with AF
下载PDF
导出
摘要 目的探讨胺碘酮对老年急性心肌梗死(AMI)合并心房颤动(AF)患者短期预后的影响。方法选择我院2012年1月至2014年12月收治的87例老年AMI合并AF患者作为研究对象,按照随机数字表法分为观察组(45例)和对照组(42例),观察组给予胺碘酮治疗,对照组给予毛花苷丙治疗。比较2组患者AF控制率、窦性心律维持效果、心室率和血压变化情况以及不良反应发生率。结果治疗后6、12、24、48h,观察组AF控制率均显著高于对照组(均P<0.05);AF转复后1个月内,观察组窦性心律维持总有效率为84%,显著高于对照组的55%(P<0.05);2组患者治疗后心室率均明显降低(P<0.05),组间比较差异无统计学意义(P>0.05);观察组不良反应发生率为7%,显著低于对照组的26%(P<0.05)。结论胺碘酮显著提高了老年AMI合并AF患者AF控制率,明显改善了患者短期预后,且不良反应少,值得临床重视。 Objective To investigate the effect of amiodarone on short-term prognosis in elderly patients with AMI complicated with AF.Methods From January 2012 to December 2014,87 cases of elderly patients with AMI and AF were selected as the research object.The observation group received the treatment of amiodarone,and the control group was given Lanatoside C treatment.The AF control rate,sinus rhythm maintenance effect,ventricular rate and blood pressure changes and adverse reactions were compared between the two groups.Results At 6,12,24,48 hafter treatment,the control rate of the observation group was significantly higher than that of the control group(P〈0.05);Within 1months after the cardioversion,the total effective rate in the observation group was 84%,significantly higher than 55%in the control group(P〈0.05);The heart rate of the two groups were significantly decreased after treatment(P〈0.05),and the difference was not statistically significant(P〈0.05).The incidence of adverse reactions in observation group was 7%,which was significantly lower than 26%in control group(P〈0.05).Conclusion Amiodarone significantly increased the AF control rate in elderly patients with AF and AMI,significantly improved the short-term prognosis of patients.It has less adverse reactions,and it is worthy of clinical attention.
作者 王健萍
出处 《山西医药杂志》 CAS 2016年第8期867-870,共4页 Shanxi Medical Journal
基金 广东省社会发展领域科技计划(2011B061300034)
关键词 心肌梗塞 心房颤动 胺碘酮 Myocardial infarction Atrial fibrillation Amiodarone
  • 相关文献

参考文献12

  • 1Angeli F,Reboldi G,Garofoli M,et al.Atrial fibrillation and mortality in patients with acute myocardial infarction:a systematic overview and meta-analysis[J].Curr Cardiol Rep,2012,14:601-610.
  • 2Silva FM,Pesaro AE,Franken M,et al.Acute management of unstable angina and non-ST segment elevation myocardial infarction[J].Einstein(Sao Paulo),2015,13(3):454-461.
  • 3Onk OA,Erkut B.Is the preoperative administration of amiodarone or metoprolol more effective in reducing atrial fibrillation:after coronary bypass surgery?[J].Medicine(Baltimore),2015,94(41):e1576.
  • 4高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:4903
  • 5Potpara TS,Balkan AF,Lip GY.Patterns in atrial fibrillation management and"real-world"adherence to guidelines in the Balkan region:an overview of the Balkan–atrial fibrillation survey[J].Eur Heart J,2015,36(30):1943-1944.
  • 6Pankert M,Salaun E,Cuisset T,et al.A new approach:left atrial appendage occlusion,as an alternative to anticoagulant,to treat patient who suffered of atrial fibrillation,acute coronary syndrome and clopidogrel resistance[J].Int J Cardiol,2016,202:900-903.
  • 7Ogiso M,Suzuki A,Shiga T,et al.Effect of intravenous amiodarone on QT and T peak-T end dispersions in patients with nonischemic heart failure treated with cardiac resynchronization-defibrillator therapy and electrical storm[J].J Arrhythm,2015,31(1):1-5.
  • 8张煜,张清艳,金兆辰,包宁,许研妍.胺碘酮联合硫酸镁治疗顽固性室性心律失常的疗效与安全性[J].中国临床药理学杂志,2012,28(2):85-87. 被引量:37
  • 9Samarin MJ,Mohrien KM,Oliphant CS.Continuous intravenous antiarrhythmic agents in the intensive care Unit:strategies for safe and effective use of amiodarone,lidocaine,and procainamide[J].Crit Care Nurs Q,2015,38(4):329-344.
  • 10来彬,邓志华.胺碘酮治疗急性心肌梗死合并心房颤动的临床疗效及安全性评价[J].中国临床药理学杂志,2015,31(12):1085-1087. 被引量:41

二级参考文献18

  • 1张华雄.硫酸镁在急性心肌梗死治疗中的应用[J].中国基层医药,2004,11(5):618-618. 被引量:4
  • 2喻莉,张建,许涛.硫酸镁、胺碘酮协同治疗体外循环心脏手术后室性心律失常疗效分析[J].微循环学杂志,2004,14(4):29-30. 被引量:2
  • 3季闽春,钱庆庆,杨耀芳.抗心律失常药胺碘酮临床药理学研究进展[J].中国临床药理学杂志,2005,21(4):299-302. 被引量:19
  • 4中华心血管杂志编委会心血管药物对策专题组.心血管药物临床试验评价方法的建议.中华心血管病杂志,1998,:405-412.
  • 5Sing SN, Flefeher RD, Fisher SG, et aL Aminodarone in patients with congestive heart and asymptomatic ventricular arrhythmia[ J]. N Eng J Med, 1995 ; 333 : 77 - 80.
  • 6Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction[J]. New England Journal of Medicine, 2010, 362: 2155-2165.
  • 7Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach the Euro heart survey on atrial fibrillation[J]. Chest Journal, 2010, 137: 263- 272.
  • 8SchmittJ, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications [J] . European Heart Journal, 2009, 30: 1038-1045.
  • 9Bahouth F, Mutlak D, Furman M, et al. Relationship of functional mitral regurgitation to new- onset atrial fibrillation in acute myocardial infarction [J]. Heart, 2010, 96: 683-688.
  • 10ANTMAN E M,ANBE D T, ARMSTRONG P W, et al. ACC/AHA guidelines for the management of pa- tients with ST-elevation myocardial infarction-execu- tive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) [J]. Circulation, 2011,110:588-636.

共引文献4999

同被引文献75

引证文献11

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部